Digital Object Identifier (DOI)
https://doi.org/10.67620/dermajournal.1730075
Received
Sep 26, 2026
Revised
Oct 11, 2026
Published
Oct 16, 2026
Аннотация
Dermatomycoses affect an estimated 20–25% of the global population. Over the past five years, this burden has been compounded by the rapid emergence of Trichophyton indotineae, a terbinafine-resistant dermatophyte first identified on the Indian subcontinent and now documented across more than 40 countries (da Silva et al., 2026). Reported resistance rates for this pathogen vary considerably across the literature, ranging from 5% to over 77%, a discrepancy risking misinterpretation as inconsistent evidence rather than a predictable consequence of study design.
Ключевые слова
—
Как цитировать
APA style
Maxmudjonov M. (2026). ANTIFUNGAL RESISTANCE IN DERMATOMYCOSES: CURRENT TREATMENT CHALLENGES. *Dermatovenereology and aesthetic medicine*, 17(3), 112. https://doi.org/10.67620/dermajournal.1730075